Search
for

    Sort by

    Research 301–330 of 1000+

    1. Combination of Low-Dose Isotretinoin and Pulsed Oral Azithromycin in the Management of Moderate to Severe Acne Clinical Drug Investigation · 2011 · 18 citations
    2. Metformin as an adjunct therapy for the treatment of moderate to severe acne vulgaris Dermatology Online Journal · 2017 · 10 citations
    3. Sodium selenate as a disease-modifying treatment for mild–moderate Alzheimer’s disease: an open-label extension study BMJ neurology open · 2021 · 8 citations
    4. Proxalutamide (GT0918) Reduces the Rate of Hospitalization in mild-to-moderate COVID-19 Female Patients: A Randomized Double-Blinded Placebo-Controlled Two-Arm Parallel Trial medRxiv (Cold Spring Harbor Laboratory) · 2021 · 5 citations
    5. Generalized hypertrichosis due to secukinumab in a patient with moderate psoriasis: A case of serendipity or zemblanity? Dermatologic therapy · 2019 · 5 citations
    6. Clinical, laboratory and psychological aspects of moderate COVID-19 in cardiovascular patients one month after discharge from the hospital Russian Journal of Cardiology · 2021 · 4 citations
    7. Adalimumab improves health-related quality of life (HRQoL) in patients with moderate to severe hidradenitis suppurativa (HS): Results from the first 12 weeks of PIONEER II Journal of The American Academy of Dermatology · 2015 · 3 citations
    8. 51840 Efficacy of the Oral JAK1/JAK2 Inhibitor Deuruxolitinib in Adult Patients with Moderate to Severe Alopecia Areata: Pooled Results from the Multinational Double-Blind, Placebo-Controlled THRIVE-AA1 and THRIVE-AA2 Phase 3 Trials Journal of the American Academy of Dermatology · 2024 · 2 citations
    9. 41701 Efficacy of the Oral JAK1/JAK2 Inhibitor CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata: Results from the Multinational Double-Blind, Placebo-Controlled THRIVE-AA1 Phase 3 Trial Journal of the American Academy of Dermatology · 2023 · 2 citations
    10. COVID-19 vaccination related exacerbations of hair loss in patients with moderate-to-severe alopecia areata on systemic therapy JAAD case reports · 2022 · 2 citations
    11. Efficacy, tolerability, and safety of montelukast versus finasteride for the treatment of moderate acne in women: A prospective, randomized, single‐blinded, active‐controlled trial Journal of Cosmetic Dermatology · 2021 · 2 citations
    12. Highly Efficient Rinse-Off/Leave-On Scalp Care Treatments to Reduce Moderate to Severe Dandruff Journal of cosmetics, dermatological sciences and applications · 2013 · 2 citations
    13. Rejection Sensitivity and Problematic Internet Use Among Medical Students: A Moderated Mediation Model Involving Loneliness and Self-Control Behavioral Sciences · 2025 · 1 citations
    14. 43927 The Impact of Treatment with Guselkumab on Skin-related Quality of Life in Male and Female Patients with Moderate to Severe Psoriasis: Results from the VOYAGE 1 and 2 Trials Journal of the American Academy of Dermatology · 2023 · 1 citations
    15. 40062 Mini pulse corticosteroid therapy with oral dexamethasone for moderate to severe alopecia areata: a multicentric study Journal of the American Academy of Dermatology · 2023 · 1 citations
    16. 605 Efficacy and safety of dupilumab in adolescent patients with moderate-to-severe atopic dermatitis Journal of Investigative Dermatology · 2019 · 1 citations
    17. Efficacy and safety of oral finasteride <i>versus</i> dutasteride in moderate-to-severe androgenetic alopecia in males based on trichoscopic and laboratory findings: a clinical comparison in Iran Journal of Dermatological Treatment · 2026
    18. A Pilot Randomized Controlled Trial Comparing the Efficacy and Safety of Oral Tofacitinib Versus Methotrexate In Moderate-to-Severe Alopecia Areata Indian Dermatology Online Journal · 2026
    19. PRP vs 5% topical Minoxidil: a dilemma in moderate male androgenetic alopecia Journal of Aesthetic Nursing · 2026
    20. Efficacy of different doses of platelet-rich plasma for moderate carpal tunnel syndrome: study protocol for a prospective, randomized, controlled trial in Guangzhou, China Trials · 2026
    21. Comprehensive single-cell transcriptomic profiling of the scalp from patients with moderate-to-severe alopecia areata Journal of Allergy and Clinical Immunology · 2026
    22. Safety and Efficacy of Mesotherapy with Placenta Polypeptide Injection for Moderate-to-Severe Sensitive Skin: A Multicenter, Randomized, Controlled Trial Clinical Cosmetic and Investigational Dermatology · 2026
    23. A 52-Week Real-Life Study of Baricitinib in Moderate to Severe Alopecia Areata: Clinical, Trichoscopic Assessment and Patient Reported Outcomes Journal of Clinical Medicine · 2025
    24. RETRACTION: Observing the Clinical Efficacy of Combined Serum Microneedle Therapy for Moderate to Severe Androgenetic Alopecia in Scalp Repair Skin Research and Technology · 2025
    25. Vitamin D and its Analogs in Treatment of Mild to Moderate Alopecia Areata: Systematic Review and Meta-Analysis. PubMed · 2025
    26. Efficacy of different doses of Platelet-Rich Plasma for Moderate Carpal Tunnel Syndrome:Study Protocol for a Prospective, Randomized, Controlled trail 2025
    27. BH06 (P075) A randomized controlled trial comparing the efficacy and safety of oral tofacitinib vs. methotrexate in moderate-to-severe alopecia areata British Journal of Dermatology · 2025
    28. Etrasimod for alopecia areata: The scenario for a less extensive and moderate form Journal of the European Academy of Dermatology and Venereology · 2025
    29. Comparison of efficacy of topical tazarotene 0.1% versus topical adapalene 0.1% in treatment of mild to moderate acne vulgaris Journal of Pakistan Association of Dermatologists · 2024
    30. Effectiveness of Finasteride in comparison to Clindamycin Solutions on Mild to Moderate Acne Vulgaris Iraqi postgraduate medical journal · 2024